Filing Details
Aura Biosciences, Inc. (NASDAQ:AURA) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:AURA
Aura Biosciences, Inc. (AURA) Reports Material Event to SEC
Filing Details Aura Biosciences, Inc. (NASDAQ:AURA) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market Context Aura…
Market Context
Aura Biosciences, Inc.'s stock currently trades at $7.25 with a market capitalization of $413.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Aura Biosciences, Inc.'s stock.
All SEC filings for Aura Biosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AURA Stock Page
Frequently Asked Questions
Where can I read AURA's SEC filings?
Browse all filings on our AURA SEC filings page.
What types of SEC filings does Aura Biosciences, Inc. file?
Public companies like Aura Biosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
